Annual Working Capital
$54.27 M
+$3.45 M+6.79%
31 December 2023
Summary:
Mereo BioPharma annual working capital is currently $54.27 million, with the most recent change of +$3.45 million (+6.79%) on 31 December 2023. During the last 3 years, it has risen by +$25.44 million (+88.20%). MREO annual working capital is now -53.66% below its all-time high of $117.12 million, reached on 31 December 2021.MREO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$72.52 M
-$5.96 M-7.59%
30 September 2024
Summary:
Mereo BioPharma quarterly working capital is currently $72.52 million, with the most recent change of -$5.96 million (-7.59%) on 30 September 2024. MREO quarterly working capital is now -52.57% below its all-time high of $152.88 million, reached on 30 June 2021.MREO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.8% | - |
| 3 y3 years | +88.2% | -52.6% |
| 5 y5 years | +133.5% | +105.7% |
MREO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -53.7% | +88.2% | -52.6% | +70.7% |
| 5 y | 5 years | -53.7% | +7331.7% | -52.6% | +9829.5% |
| alltime | all time | -53.7% | +7331.7% | -52.6% | +9829.5% |
Mereo BioPharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $72.52 M(-7.6%) |
| June 2024 | - | $78.47 M(+84.7%) |
| Mar 2024 | - | $42.49 M(-21.7%) |
| Dec 2023 | $54.27 M(+6.8%) | $54.27 M(+17.0%) |
| June 2023 | - | $46.38 M(-8.7%) |
| Dec 2022 | $50.82 M(-56.6%) | $50.82 M(-10.1%) |
| June 2022 | - | $56.52 M(-51.7%) |
| Dec 2021 | $117.12 M(+306.1%) | $117.12 M(-23.4%) |
| June 2021 | - | $152.88 M(+430.1%) |
| Dec 2020 | $28.84 M | $28.84 M(-47.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $54.54 M(+7368.8%) |
| Dec 2019 | $730.30 K(-96.9%) | $730.30 K(-97.9%) |
| June 2019 | - | $35.26 M(+51.7%) |
| Dec 2018 | $23.24 M(-67.9%) | $23.24 M(-49.3%) |
| June 2018 | - | $45.88 M(-36.6%) |
| Dec 2017 | $72.38 M(+1.9%) | $72.38 M(+7.4%) |
| June 2017 | - | $67.41 M(-5.1%) |
| Dec 2016 | $71.03 M(+385.9%) | $71.03 M(-22.8%) |
| June 2016 | - | $92.03 M(+529.5%) |
| Dec 2015 | $14.62 M | $14.62 M |
FAQ
- What is Mereo BioPharma annual working capital?
- What is the all time high annual working capital for Mereo BioPharma?
- What is Mereo BioPharma annual working capital year-on-year change?
- What is Mereo BioPharma quarterly working capital?
- What is the all time high quarterly working capital for Mereo BioPharma?
What is Mereo BioPharma annual working capital?
The current annual working capital of MREO is $54.27 M
What is the all time high annual working capital for Mereo BioPharma?
Mereo BioPharma all-time high annual working capital is $117.12 M
What is Mereo BioPharma annual working capital year-on-year change?
Over the past year, MREO annual working capital has changed by +$3.45 M (+6.79%)
What is Mereo BioPharma quarterly working capital?
The current quarterly working capital of MREO is $72.52 M
What is the all time high quarterly working capital for Mereo BioPharma?
Mereo BioPharma all-time high quarterly working capital is $152.88 M